In PD-L1 antibody-resistant tumor tissues, cancer cell growth is inhibited by removing exoPD-L1 by knocking out RAB27A (member RAS oncogene family) and NSMASE2 (sphingomyelin phosphodiesterase 3) (96). Here, SMPD3 is linked to cancer.